Industry 4.0 and technological skills: these are the topics Luca Crippa’s speech at the AboutFuture Leaders’ Talks was focused on

The AboutFuture Leaders’ Talks 2021 – the annual event promoted by AboutPharma to exhaustively investigate, through the interaction between top managers of the life sciences industry, the role of the pharmaceutical companies on the changes currently taking place – was held on September 23.

The two round tables that saw the participation of Luca Crippa, CEO & Managing Director of IBSA Farmaceutici, invigorated the discussion on the changes to be adopted quickly in order to remove bureaucratic and organizational obstacles and solve the pandemic crisis, while protecting the health of citizens.

"The National Recovery and Resilience Plan is a precious opportunity to modernize our health system, making it more efficient and connected to international strategic priorities, as well as to promote a profound transformation of the healthcare supply chain", explained Luca Crippa in the interview at the end of the round table.

The PNRR (Piano Nazionale di Ripresa e Resilienza, “National Recovery and Resilience Plan”) is a great opportunity for the technological advancement of Italy, of the pharmaceutical industry as a whole and of IBSA Farmaceutici specifically.

In a Country like ours which, together with Germany, is at the forefront of the pharmaceutical production, being an industry 4.0 means moving to a higher level of technology, quality and safety, implementing the consolidation of the Italian leadership in the sector.

However, the technological and qualitative advancement of the pharmaceutical industry should also be matched by the reinforcement of exports, which is only possible through a constant and collaborative communication with the Institutions, to facilitate export procedures and restore value to the entire national economic system.

Finally, it is necessary to enhance the Italian health system, which is characterized by real global excellences. Milan, Naples, Rome and many other realities, also smaller, are actual jewels in the crown of a healthcare system that sees patients coming from all over the world.

For these reasons, speeding up collaborations and exchanges, stimulating innovation, promoting the economic and occupational growth as well as the sustainability and safety of processes are the milestones of the future of IBSA Farmaceutici, a company which confirms once again its commitment to the development of new technologies and therapeutic solutions capable of offering positive answers to the unmet needs of patients.